⌘K

Home/Filings/4/0001345281-23-000008

4//SEC Filing

KAY CHRISTINA 4

Accession 0001345281-23-000008

CIK 0001016504other

View on SEC.gov Company Profile

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 6:31 PM ET

Size

5.4 KB

Accession

0001345281-23-000008

Insider Transaction Report

Form 4

Period: 2023-11-28

INTEGRATED BIOPHARMA INCINBP

DirectorExecutive Vice President

Transactions

Award
Stock Option (right to buy)
2023-11-28+150,000→ 150,000 total
Exercise: $0.26Exp: 2033-11-28→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1

filerCIK 0001064901

Filing Metadata

Form type: 4
Filed: Nov 28, 7:00 PM ET
Accepted: Nov 29, 6:31 PM ET
Size: 5.4 KB

View on SEC.gov